Stratec SE (SBS.DE)
- Previous Close
43.35 - Open
43.30 - Bid 43.35 x 3600
- Ask 43.70 x 6200
- Day's Range
43.30 - 43.30 - 52 Week Range
36.00 - 69.00 - Volume
36 - Avg. Volume
8,826 - Market Cap (intraday)
526.35M - Beta (5Y Monthly) 0.11
- PE Ratio (TTM)
43.30 - EPS (TTM)
1.00 - Earnings Date Aug 9, 2024
- Forward Dividend & Yield 0.55 (1.27%)
- Ex-Dividend Date May 20, 2024
- 1y Target Est
104.44
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
www.stratec.comRecent News: SBS.DE
Performance Overview: SBS.DE
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBS.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBS.DE
Valuation Measures
Market Cap
526.96M
Enterprise Value
634.12M
Trailing P/E
43.35
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.09
Price/Book (mrq)
2.30
Enterprise Value/Revenue
2.51
Enterprise Value/EBITDA
16.04
Financial Highlights
Profitability and Income Statement
Profit Margin
4.81%
Return on Assets (ttm)
3.65%
Return on Equity (ttm)
5.29%
Revenue (ttm)
252.3M
Net Income Avi to Common (ttm)
12.14M
Diluted EPS (ttm)
1.00
Balance Sheet and Cash Flow
Total Cash (mrq)
19.13M
Total Debt/Equity (mrq)
61.98%
Levered Free Cash Flow (ttm)
-23.93M
Research Analysis: SBS.DE
Company Insights: SBS.DE
SBS.DE does not have Company Insights